Jakob Dupont
Director/Board Member at IMUGENE LIMITED
Net worth: 208 600 $ as of 2024-04-29
Profile
Jakob Dupont is currently a Non-Executive Director at Imugene Ltd., a Director at Apexigen America, Inc., an Independent Director at Pyxis Oncology, Inc., an Executive Partner at Sofinnova Investments, Inc., and an Advisor at Ambrx, Inc. Previously, he worked as a Global Director-Medical at Genentech, Inc. from 2006 to 2011, an Independent Director at Apexigen, Inc. from 2020 to 2023, the VP & Global Head-Gynecologic Cancer Development at Genentech, Inc. from 2017 to 2018, the Chief Medical Officer & Senior Vice President at Mereo BioPharma 5, Inc. from 2011 to 2017, and the Chief Medical Officer at Gossamer Bio, Inc. from 2018 to 2020.
Dr. Dupont's education includes a graduate degree from New York University in 1991, an undergraduate degree from Vassar College in 1987, and a doctorate degree from Weill Cornell Medical College in 1996.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-03-01 | 290,794 ( 0.24% ) | 203 556 $ | 2024-04-29 | |
IMUGENE LTD
0.00% | 2024-01-11 | 89,286 ( 0.00% ) | 5 044 $ | 2024-04-29 |
PYXIS ONCOLOGY, INC.
-.--% | 2024-04-17 | 0 ( -.--% ) | - $ | 2024-04-29 |
Jakob Dupont active positions
| Companies | Position | Start |
|---|---|---|
| IMUGENE LIMITED | Director/Board Member | 2022-09-06 |
| AMBRX INC | Consultant / Advisor | 2021-02-28 |
| PYXIS ONCOLOGY, INC. | Director/Board Member | 2023-08-22 |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Director/Board Member | 2020-08-18 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 2023-04-30 |
Former positions of Jakob Dupont
| Companies | Position | End |
|---|---|---|
| APEXIGEN, INC. | Director/Board Member | 2023-08-22 |
| ATARA BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-05-11 |
| GOSSAMER BIO, INC. | Chief Tech/Sci/R&D Officer | 2020-04-30 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2018-11-30 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Jakob Dupont
| Vassar College | Undergraduate Degree |
| New York University | Graduate Degree |
| Weill Cornell Medical College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| GOSSAMER BIO, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| APEXIGEN, INC. | Health Technology |
| IMUGENE LIMITED | Health Technology |
| PYXIS ONCOLOGY, INC. | Health Technology |
| Private companies | 6 |
|---|---|
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Health Services |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Finance |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- Jakob Dupont
